2,014 results on '"Shyr, Yu"'
Search Results
152. Supplementary Figure 2 from A Kinome-Wide Screen Identifies the Insulin/IGF-I Receptor Pathway as a Mechanism of Escape from Hormone Dependence in Breast Cancer
153. Breakthrough SARS-CoV-2 infections among patients with cancer following two and three doses of COVID-19 mRNA vaccines: a retrospective observational study from the COVID-19 and Cancer Consortium
154. PP.48 Breakthrough SARS-CoV-2 Infection and COVID-19 Disease Severity in Lung Cancer Patients
155. Primary endpoints to assess the efficacy of novel therapeutic approaches in epidermal growth factor receptor-mutated, surgically resectable non-small cell lung cancer: A review
156. Power and sample sizes estimation in clinical trials with treatment switching in intention-to-treat analysis: a simulation study
157. Optimal treatment by invoking biologic clusters in renal cell carcinoma (OPTIC RCC).
158. Multicenter Phase II Trial of the PARP Inhibitor Olaparib in Recurrent IDH1- and IDH2-mutant Glioma
159. Randomized Trial of Olaparib With or Without Cediranib for Metastatic Castration-Resistant Prostate Cancer: The Results From National Cancer Institute 9984
160. Comparative Treatment Outcomes for Idiopathic Subglottic Stenosis: 5‐Year Update
161. The Genetic Landscape of Familial Pulmonary Fibrosis
162. Additional file 1 of Power and sample sizes estimation in clinical trials with treatment switching in intention-to-treat analysis: a simulation study
163. Data Safety Monitoring Boards
164. Patients Recently Treated for B-lymphoid Malignancies Show Increased Risk of Severe COVID-19
165. Are clear cell carcinomas of the ovary and endometrium phenotypically identical? A proteomic analysis
166. Design and Conduct of Clinical Trials for Breast Cancer
167. Contributors
168. Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19
169. Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancer
170. RnaSeqSampleSize: real data based sample size estimation for RNA sequencing
171. New tools for the quantitative assessment of prodrug delivery and neurotoxicity
172. Preprocessing Significantly Improves the Peptide/Protein Identification Sensitivity of High-resolution Isobarically Labeled Tandem Mass Spectrometry Data
173. Enforced expression of E47 has differential effects on Lmo2-induced T-cell leukemias
174. Using theHER2/CEP17FISH Ratio to Predict Pathologic Complete Response Following Neoadjuvant Anti-HER2 Doublet Therapy in HER2+ Breast Cancer
175. Cox Proportional Hazard Ratios Overestimate Survival Benefit of Immune Checkpoint Inhibitors: Cox-TEL Adjustment and Meta-Analyses of Programmed Death-Ligand 1 Expression and Immune Checkpoint Inhibitor Survival Benefit
176. A Single Nucleotide Polymorphism in SH2B3/LNK Promotes Hypertension Development and Renal Damage
177. A Mechanistic Clinical Trial Using ( R )- Versus (S )-Propafenone to Test RyR2 (Ryanodine Receptor) Inhibition for the Prevention of Atrial Fibrillation Induction
178. Non-Invasive Glutamine PET Reflects Pharmacological Inhibition of BRAFV600E In Vivo
179. Utility of [18F]FSPG PET to Image Hepatocellular Carcinoma: First Clinical Evaluation in a US Population
180. Implementation and evaluation of an integrated computerized asthma management system in a pediatric emergency department: A randomized clinical trial
181. Prediction of Antitumor Response
182. Power and sample sizes estimation in clinical trials with treatment switching in intention-to-treat analysis: a simulation study
183. Scalable and model-free detection of spatial patterns and colocalization
184. Associations of influenza vaccination with severity of immune-related adverse events in patients with advanced thoracic cancers on immune checkpoint inhibitors
185. Analysis of Cancer Survival Associated With Immune Checkpoint Inhibitors After Statistical Adjustment
186. Sample size determination for paired right-censored data based on the difference of Kaplan–Meier estimates
187. LKB1 Loss Induces Characteristic Patterns of Gene Expression in Human Tumors Associated with NRF2 Activation and Attenuation of PI3K-AKT
188. Epidermal growth factor receptor signaling pathway is frequently altered in ampullary carcinoma at protein and genetic levels
189. Dose to the inferior pharyngeal constrictor predicts prolonged gastrostomy tube dependence with concurrent intensity-modulated radiation therapy and chemotherapy for locally-advanced head and neck cancer
190. Feasibility trial for primary stroke prevention in children with sickle cell anemia in Nigeria (SPIN trial)
191. Longitudinal Cell-Free DNA Analysis in Patients with Small Cell Lung Cancer Reveals Dynamic Insights into Treatment Efficacy and Disease Relapse
192. Statistical Consideration in Predictive and Prognostic Markers
193. Sample Size Calculation for Differential Expression Analysis of RNA-Seq Data
194. Multisite external validation of a risk prediction model for the diagnosis of blood stream infections in febrile pediatric oncology patients without severe neutropenia
195. Nascent RNA sequencing analysis provides insights into enhancer-mediated gene regulation
196. Aurora Kinase A Promotes Inflammation and Tumorigenesis in Mice and Human Gastric Neoplasia
197. Patients Recently Treated for B-lymphoid Malignancies Show Increased Risk of Severe COVID-19
198. Pyruvate Kinase Muscle Isoenzyme 2 (PKM2) Expression Is Associated with Overall Survival in Pancreatic Ductal Adenocarcinoma
199. Abstract 5018: A comprehensive analysis of genomic determinants of response to immune checkpoint inhibitor-based immunotherapy
200. Abstract CT170: A phase 1/2 study of olaparib in combination with ramucirumab in metastatic gastric and gastroesophageal junction adenocarcinoma (GEJ)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.